Annual EBIT
$21.48 M
-$17.98 M-45.56%
March 31, 2024
Summary
- As of February 10, 2025, TARO annual earnings before interest & taxes is $21.48 million, with the most recent change of -$17.98 million (-45.56%) on March 31, 2024.
- During the last 3 years, TARO annual EBIT has risen by +$411.19 million (+105.51%).
Performance
TARO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
$8.78 M
-$7.10 M-44.70%
March 31, 2024
Summary
- As of February 10, 2025, TARO quarterly earnings before interest & taxes is $8.78 million, with the most recent change of -$7.10 million (-44.70%) on March 31, 2024.
- Over the past year, TARO quarterly EBIT has dropped by -$7.10 million (-44.70%).
Performance
TARO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
$21.48 M
-$22.24 M-50.87%
March 31, 2024
Summary
- As of February 10, 2025, TARO TTM earnings before interest & taxes is $21.48 million, with the most recent change of -$22.24 million (-50.87%) on March 31, 2024.
- Over the past year, TARO TTM EBIT has dropped by -$22.24 million (-50.87%).
Performance
TARO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TARO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.6% | -44.7% | -50.9% |
| 3 y3 years | +105.5% | +101.8% | +105.5% |
| 5 y5 years | -94.0% | -84.9% | -93.4% |
TARO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.0% | -1913.9% | -76.3% | -374.6% | -73.0% | -1929.7% |
| 5 y | 5-year | -94.0% | -1913.9% | -92.0% | -5755.1% | -93.4% | -1932.9% |
| alltime | all time | -96.6% | -1913.9% | -95.9% | -5755.1% | -96.8% | -1932.9% |
Taro Pharmaceutical Industries EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $21.48 M(-45.6%) | $8.78 M(-44.7%) | $21.48 M(-50.9%) |
| Dec 2023 | - | $15.88 M(+235.1%) | $43.73 M(+50.1%) |
| Sep 2023 | - | $4.74 M(-159.8%) | $29.12 M(+65.8%) |
| Jun 2023 | - | -$7.92 M(-125.5%) | $17.57 M(-55.5%) |
| Mar 2023 | $39.47 M(-50.4%) | $31.03 M(+2325.8%) | $39.47 M(-351.7%) |
| Dec 2022 | - | $1.28 M(-118.8%) | -$15.68 M(-178.2%) |
| Sep 2022 | - | -$6.82 M(-148.8%) | $20.04 M(-62.0%) |
| Jun 2022 | - | $13.98 M(-158.0%) | $52.72 M(-33.7%) |
| Mar 2022 | $79.51 M(-120.4%) | -$24.12 M(-165.2%) | $79.51 M(-120.2%) |
| Dec 2021 | - | $36.99 M(+43.0%) | -$393.12 M(-0.2%) |
| Sep 2021 | - | $25.87 M(-36.6%) | -$393.80 M(+4.0%) |
| Jun 2021 | - | $40.77 M(-108.2%) | -$378.70 M(-2.8%) |
| Mar 2021 | -$389.71 M(-230.4%) | -$496.75 M(-1468.1%) | -$389.71 M(-280.0%) |
| Dec 2020 | - | $36.31 M(-11.4%) | $216.47 M(-9.2%) |
| Sep 2020 | - | $40.96 M(+37.6%) | $238.36 M(-8.3%) |
| Jun 2020 | - | $29.77 M(-72.8%) | $259.96 M(-13.0%) |
| Mar 2020 | $298.76 M(-16.3%) | $109.44 M(+88.0%) | $298.76 M(-8.2%) |
| Dec 2019 | - | $58.20 M(-7.0%) | $325.62 M(-6.0%) |
| Sep 2019 | - | $62.56 M(-8.8%) | $346.36 M(-4.5%) |
| Jun 2019 | - | $68.56 M(-49.7%) | $362.52 M(+1.5%) |
| Mar 2019 | $357.11 M(+22.0%) | $136.30 M(+72.7%) | $357.11 M(+26.0%) |
| Dec 2018 | - | $78.93 M(+0.3%) | $283.44 M(+5.7%) |
| Sep 2018 | - | $78.72 M(+24.6%) | $268.13 M(-3.6%) |
| Jun 2018 | - | $63.16 M(+0.8%) | $278.19 M(-4.9%) |
| Mar 2018 | $292.67 M(-47.8%) | $62.62 M(-1.6%) | $292.67 M(-22.5%) |
| Dec 2017 | - | $63.63 M(-28.3%) | $377.77 M(-14.8%) |
| Sep 2017 | - | $88.78 M(+14.4%) | $443.17 M(-10.6%) |
| Jun 2017 | - | $77.64 M(-47.4%) | $495.95 M(-11.6%) |
| Mar 2017 | $560.93 M(-12.0%) | $147.72 M(+14.5%) | $560.93 M(-9.1%) |
| Dec 2016 | - | $129.03 M(-8.9%) | $616.78 M(-6.7%) |
| Sep 2016 | - | $141.56 M(-0.7%) | $661.12 M(+2.4%) |
| Jun 2016 | - | $142.62 M(-29.9%) | $645.54 M(+1.3%) |
| Mar 2016 | $637.29 M(+9.4%) | $203.57 M(+17.4%) | $637.29 M(-1.4%) |
| Dec 2015 | - | $173.37 M(+37.6%) | $646.44 M(+2.2%) |
| Sep 2015 | - | $125.98 M(-6.2%) | $632.39 M(-5.5%) |
| Jun 2015 | - | $134.37 M(-36.8%) | $668.99 M(+14.8%) |
| Mar 2015 | $582.61 M(+30.8%) | $212.72 M(+33.5%) | $582.61 M(+20.4%) |
| Dec 2014 | - | $159.32 M(-2.0%) | $484.01 M(+5.2%) |
| Sep 2014 | - | $162.58 M(+238.8%) | $460.13 M(+9.6%) |
| Jun 2014 | - | $47.99 M(-57.9%) | $419.87 M(-5.7%) |
| Mar 2014 | $445.42 M(+31.6%) | $114.12 M(-15.7%) | $445.42 M(+13.4%) |
| Dec 2013 | - | $135.43 M(+10.7%) | $392.94 M(+7.7%) |
| Sep 2013 | - | $122.31 M(+66.3%) | $364.84 M(+9.6%) |
| Jun 2013 | - | $73.55 M(+19.3%) | $332.94 M(-1.9%) |
| Mar 2013 | $338.38 M(+416.6%) | $61.64 M(-42.6%) | $339.45 M(-1.3%) |
| Dec 2012 | - | $107.33 M(+18.7%) | $343.93 M(+10.3%) |
| Sep 2012 | - | $90.41 M(+12.9%) | $311.85 M(+4.1%) |
| Jun 2012 | - | $80.06 M(+21.1%) | $299.62 M(+18.9%) |
| Mar 2012 | $65.50 M(-69.2%) | $66.13 M(-12.1%) | $252.04 M(+15.0%) |
| Dec 2011 | $212.93 M(+164.1%) | $75.25 M(-3.7%) | $219.15 M(+36.1%) |
| Sep 2011 | - | $78.18 M(+140.7%) | $161.06 M(+52.3%) |
| Jun 2011 | - | $32.48 M(-2.3%) | $105.79 M(+8.9%) |
| Mar 2011 | - | $33.23 M(+93.6%) | $97.10 M(+23.2%) |
| Dec 2010 | $80.63 M(+27.5%) | $17.17 M(-25.1%) | $78.81 M(-9.1%) |
| Sep 2010 | - | $22.91 M(-3.7%) | $86.66 M(+13.4%) |
| Jun 2010 | - | $23.79 M(+59.2%) | $76.41 M(+13.0%) |
| Mar 2010 | - | $14.94 M(-40.3%) | $67.61 M(-2.6%) |
| Dec 2009 | $63.26 M(+41.0%) | $25.02 M(+97.6%) | $69.41 M(+85.1%) |
| Sep 2009 | - | $12.66 M(-15.6%) | $37.50 M(-4.7%) |
| Jun 2009 | - | $15.00 M(-10.4%) | $39.36 M(-5.7%) |
| Mar 2009 | - | $16.73 M(-342.8%) | $41.74 M(+66.9%) |
| Dec 2008 | $44.86 M(-29.2%) | -$6.89 M(-147.5%) | $25.01 M(-21.6%) |
| Sep 2008 | - | $14.52 M(-16.4%) | $31.90 M(+83.6%) |
| Jun 2008 | - | $17.38 M(-391.4%) | $17.38 M(+29.8%) |
| Dec 2007 | $63.36 M(-190.1%) | - | - |
| Dec 2006 | -$70.35 M(-699.0%) | - | - |
| Dec 2005 | $11.75 M(-2376.4%) | -$5.96 M(-259.1%) | $13.39 M(-43.1%) |
| Sep 2005 | - | $3.75 M(-55.0%) | $23.53 M(+6.0%) |
| Jun 2005 | - | $8.33 M(+14.5%) | $22.19 M(-694.0%) |
| Mar 2005 | - | $7.28 M(+74.3%) | -$3.74 M(+622.6%) |
| Dec 2004 | -$516.00 K | $4.17 M(+73.3%) | -$517.00 K(-103.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2004 | - | $2.41 M(-113.7%) | $14.21 M(-54.8%) |
| Jun 2004 | - | -$17.59 M(-267.7%) | $31.46 M(-53.1%) |
| Mar 2004 | - | $10.49 M(-44.5%) | $67.06 M(-10.2%) |
| Dec 2003 | $74.69 M(+40.2%) | $18.90 M(-3.9%) | $74.69 M(+4.7%) |
| Sep 2003 | - | $19.66 M(+9.2%) | $71.31 M(+8.5%) |
| Jun 2003 | - | $18.01 M(-0.6%) | $65.73 M(+10.2%) |
| Mar 2003 | - | $18.12 M(+16.7%) | $59.63 M(+12.0%) |
| Dec 2002 | $53.26 M(+62.5%) | $15.53 M(+10.3%) | $53.26 M(+8.8%) |
| Sep 2002 | - | $14.07 M(+18.1%) | $48.93 M(+9.2%) |
| Jun 2002 | - | $11.91 M(+1.4%) | $44.79 M(+11.1%) |
| Mar 2002 | - | $11.74 M(+4.9%) | $40.33 M(+23.0%) |
| Dec 2001 | $32.77 M(+49.2%) | $11.20 M(+12.6%) | $32.77 M(+0.5%) |
| Sep 2001 | - | $9.94 M(+33.5%) | $32.61 M(+20.0%) |
| Jun 2001 | - | $7.45 M(+77.7%) | $27.19 M(+18.2%) |
| Mar 2001 | - | $4.19 M(-62.0%) | $23.00 M(+4.7%) |
| Dec 2000 | $21.96 M(+103.2%) | $11.04 M(+144.5%) | $21.96 M(+65.9%) |
| Sep 2000 | - | $4.51 M(+38.4%) | $13.23 M(+10.4%) |
| Jun 2000 | - | $3.26 M(+3.3%) | $11.99 M(+4.0%) |
| Mar 2000 | - | $3.15 M(+36.8%) | $11.53 M(+8.7%) |
| Dec 1999 | $10.81 M(+68.2%) | $2.31 M(-29.4%) | $10.61 M(-132.9%) |
| Sep 1999 | - | $3.27 M(+16.6%) | -$32.27 M(+76.0%) |
| Jun 1999 | - | $2.80 M(+25.6%) | -$18.34 M(+278.7%) |
| Mar 1999 | - | $2.23 M(-105.5%) | -$4.84 M(-25.2%) |
| Dec 1998 | $6.42 M(+57.8%) | -$40.58 M(-335.9%) | -$6.47 M(-118.5%) |
| Sep 1998 | - | $17.20 M(+5.5%) | $34.97 M(+78.7%) |
| Jun 1998 | - | $16.30 M(+2616.7%) | $19.57 M(+347.7%) |
| Mar 1998 | - | $600.00 K(-31.1%) | $4.37 M(0.0%) |
| Dec 1997 | $4.07 M(-15.2%) | $871.00 K(-51.6%) | $4.37 M(-7.0%) |
| Sep 1997 | - | $1.80 M(+63.6%) | $4.70 M(+9.3%) |
| Jun 1997 | - | $1.10 M(+83.3%) | $4.30 M(-8.5%) |
| Mar 1997 | - | $600.00 K(-50.0%) | $4.70 M(-2.1%) |
| Dec 1996 | $4.80 M(-9.4%) | $1.20 M(-14.3%) | $4.80 M(-117.0%) |
| Sep 1996 | - | $1.40 M(-6.7%) | -$28.20 M(+67.9%) |
| Jun 1996 | - | $1.50 M(+114.3%) | -$16.80 M(+223.1%) |
| Mar 1996 | - | $700.00 K(-102.2%) | -$5.20 M(-198.1%) |
| Dec 1995 | $5.30 M(-25.4%) | -$31.80 M(-348.4%) | $5.30 M(-65.1%) |
| Sep 1995 | - | $12.80 M(-2.3%) | $15.20 M(+23.6%) |
| Jun 1995 | - | $13.10 M(+17.0%) | $12.30 M(+33.7%) |
| Mar 1995 | - | $11.20 M(-151.1%) | $9.20 M(+29.6%) |
| Dec 1994 | $7.10 M(+407.1%) | -$21.90 M(-321.2%) | $7.10 M(-27.6%) |
| Sep 1994 | - | $9.90 M(-1.0%) | $9.80 M(+55.6%) |
| Jun 1994 | - | $10.00 M(+9.9%) | $6.30 M(+61.5%) |
| Mar 1994 | - | $9.10 M(-147.4%) | $3.90 M(+178.6%) |
| Dec 1993 | $1.40 M(-26.3%) | -$19.20 M(-400.0%) | $1.40 M(-93.2%) |
| Sep 1993 | - | $6.40 M(-15.8%) | $20.50 M(+37.6%) |
| Jun 1993 | - | $7.60 M(+15.2%) | $14.90 M(+91.0%) |
| Mar 1993 | - | $6.60 M(-6700.0%) | $7.80 M(+290.0%) |
| Dec 1992 | $1.90 M(-34.5%) | -$100.00 K(-112.5%) | $2.00 M(-39.4%) |
| Sep 1992 | - | $800.00 K(+60.0%) | $3.30 M(0.0%) |
| Jun 1992 | - | $500.00 K(-37.5%) | $3.30 M(-2.9%) |
| Mar 1992 | - | $800.00 K(-33.3%) | $3.40 M(+9.7%) |
| Dec 1991 | $2.90 M(+222.2%) | $1.20 M(+50.0%) | $3.10 M(-146.3%) |
| Sep 1991 | - | $800.00 K(+33.3%) | -$6.70 M(+59.5%) |
| Jun 1991 | - | $600.00 K(+20.0%) | -$4.20 M(+180.0%) |
| Mar 1991 | - | $500.00 K(-105.8%) | -$1.50 M(-31.8%) |
| Dec 1990 | $900.00 K(+80.0%) | -$8.60 M(-360.6%) | -$2.20 M(+29.4%) |
| Sep 1990 | - | $3.30 M(0.0%) | -$1.70 M(+6.3%) |
| Jun 1990 | - | $3.30 M(-1750.0%) | -$1.60 M(-27.3%) |
| Mar 1990 | - | -$200.00 K(-97.5%) | -$2.20 M(-466.7%) |
| Dec 1989 | $500.00 K(+66.7%) | -$8.10 M(-338.2%) | $600.00 K(-62.5%) |
| Sep 1989 | - | $3.40 M(+25.9%) | $1.60 M(+433.3%) |
| Jun 1989 | - | $2.70 M(+3.8%) | $300.00 K(+50.0%) |
| Mar 1989 | - | $2.60 M(-136.6%) | $200.00 K(>+9900.0%) |
| Dec 1988 | $300.00 K(0.0%) | -$7.10 M(-438.1%) | $0.00(-100.0%) |
| Sep 1988 | - | $2.10 M(-19.2%) | $1.40 M(+7.7%) |
| Jun 1988 | - | $2.60 M(+8.3%) | $1.30 M(+85.7%) |
| Mar 1988 | - | $2.40 M(-142.1%) | $700.00 K(+133.3%) |
| Dec 1987 | $300.00 K | -$5.70 M(-385.0%) | $300.00 K(-95.0%) |
| Sep 1987 | - | $2.00 M(0.0%) | $6.00 M(+50.0%) |
| Jun 1987 | - | $2.00 M(0.0%) | $4.00 M(+100.0%) |
| Mar 1987 | - | $2.00 M | $2.00 M |
FAQ
- What is Taro Pharmaceutical Industries annual earnings before interest & taxes?
- What is the all time high annual EBIT for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual EBIT year-on-year change?
- What is Taro Pharmaceutical Industries quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly EBIT year-on-year change?
- What is Taro Pharmaceutical Industries TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM EBIT year-on-year change?
What is Taro Pharmaceutical Industries annual earnings before interest & taxes?
The current annual EBIT of TARO is $21.48 M
What is the all time high annual EBIT for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual earnings before interest & taxes is $637.29 M
What is Taro Pharmaceutical Industries annual EBIT year-on-year change?
Over the past year, TARO annual earnings before interest & taxes has changed by -$17.98 M (-45.56%)
What is Taro Pharmaceutical Industries quarterly earnings before interest & taxes?
The current quarterly EBIT of TARO is $8.78 M
What is the all time high quarterly EBIT for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly earnings before interest & taxes is $212.72 M
What is Taro Pharmaceutical Industries quarterly EBIT year-on-year change?
Over the past year, TARO quarterly earnings before interest & taxes has changed by -$7.10 M (-44.70%)
What is Taro Pharmaceutical Industries TTM earnings before interest & taxes?
The current TTM EBIT of TARO is $21.48 M
What is the all time high TTM EBIT for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM earnings before interest & taxes is $668.99 M
What is Taro Pharmaceutical Industries TTM EBIT year-on-year change?
Over the past year, TARO TTM earnings before interest & taxes has changed by -$22.24 M (-50.87%)